In the 7 years since it was first approved by the FDA, GILENYA has become the most prescribed* once-a-day† pill for relapsing multiple sclerosis (MS)
GILENYA® was the first pill proven to treat relapsing forms of MS in adults. It completely changed the way we think about treatment, prompting thousands of people to ask their health care professionals, "Could GILENYA, an oral relapsing MS treatment, be right for me?"
If you're asking yourself the same question, you've come to the right place. Here's where you can learn more about GILENYAand how it could work for you:
*Most prescribed as of Q1 2018.
†GILENYA can result in a slow heart rate when first taken. You will be observed by a health care professional for at least 6 hours after you take your first dose. You may need to repeat this monitoring if you miss a dose or are a child who is moving to 0.5 mg from the 0.25 mg dose.
‡The mechanism of how GILENYA works in MS is unknown.